Profitelligence Profitelligence · Filing Ledger Search all insiders →

Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Kemps-polanco Reshema

Over the trailing 90 days, Kemps-polanco Reshema (Director at CHARLES RIVER LABORATORIES INTERNATIONAL, INC.) bought $350K of stock in CRL, per 2 SEC Form 4 transactions.

Role
Director
Companies
CRL
Window
Trailing 90 days · 2 transactions · CIK 2009357
Net activity
+$350K ($350K bought · $0 sold)

By Company (Trailing 90 Days)

SymbolCompanyTxnsBoughtSoldNet
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.2$350K$350K

Transactions (2)

DateSymbolTypeSharesValueDescription
2026-05-08CRLBuy1.4K$255KGrant, award or other acquisition
2026-05-08CRLBuy535$95KGrant, award or other acquisition

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Kemps-polanco's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free